Amgen Names Howard Chang as Chief Scientific Officer

AMGN

By Stephen Nakrosis

Amgen on Wednesday said Howard Chang will join the company as senior vice president of research, effective Dec. 16.

The company said Chang, who will also serve as chief scientific officer, will establish and lead research priorities within its rare disease, oncology, inflammation and cardiometabolic therapeutic areas.

Chang succeeds Ray Deshaies, whose departure was announced earlier this year.

Write to Stephen Nakrosis at stephen.nakrosis@wsj.com

(END) Dow Jones Newswires

11-20-24 1638ET